Invitrogen teams with Inter'l Regulome Consortium

The International Regulome Consortium (IRC) has signed a letter of intent with Invitrogen Corp to develop tools for stem cell research. IRC will use Invitrogen's expertise in stem cell biology to accelerate its research into determining how stem cells give rise to specialized cells such as neurons. IRC is a third generation, international genomics project involving 58 researchers from 34 institutions in 12 countries. It is headquartered in Canada under the leadership of Dr Michael Rudnicki, a senior scientist at the Ottawa Health Research Institute….